Sentiment · ISRG
Lobbying Spend for ISRG
AI-generated plain-English read of lobbying spend for ISRG. Updated daily.
Moderate lobbying, declining
highModerate spend winding down. Likely resolved the issue that drove it, or pulling back resources. No clean signal — read other channels.
What will probably happen
- Easing spend typically means prior policy battles are resolved or de-prioritized. Neutral from a risk standpoint; investigate whether the issue resolved favorably.
- Issue concentration is high (HEALTH ISSUES dominates). The policy outcome of that specific area will drive whether this spend was effective.
What to do
- If you HOLD this stock
- Lobbying is pulling back. If the policy issue resolved favorably, this is a positive. If unresolved, investigate before adding exposure.
- If you're EVALUATING this stock
- No sharp lobbying signal to factor into entry timing. Evaluate on fundamentals.
- If you trade OPTIONS
- No clean options signal derived from this lobbying read.
54 quarters of history with $5.97M in total spend — sufficient data for a reliable trajectory read.
Technical details
Technical analysis
- Spend tier
- Moderate
- Trajectory
- Declining
- Last quarter
- $220.0K
- Last 4Q total
- $760.0K
- Prior 4Q total
- $860.0K
- Top issue area
- HEALTH ISSUES (74% of spend)
- Top registrant
- INTUITIVE SURGICAL, INC. (80% of spend)
- Registrant base
- In house
- Quarters on record
- 54
- Unique issue areas
- 6
- Unique registrants
- 6
- Issue concentration
- Laser focused
Key levels
| Level | Value |
|---|---|
| total amount | 5,970,000 |
| last 4q total | 760,000 |
| top issue pct | 0.741 |
| prior 4q total | 860,000 |
| top registrant pct | 0.796 |
| last quarter amount | 220,000 |
Caveats
- Lobbying disclosures are quarterly and reflect activity already past. The signal is structural, not timing.
- A single issue area dominates spend (HEALTH ISSUES, 74%). Read the policy implication of THAT specific issue rather than the aggregate dollar number.
- The primary registrant appears to be an in-house government-affairs operation. In-house lobbying may not be captured in full by third-party disclosure data.